.Pharmacolibrary.Drugs.V_Various.V09I_TumourDetection.V09IX17_Psma100718f.Psma100718f .Pharmacolibrary.Drugs.V_Various.V09I_TumourDetection.V09IX17_Psma100718f.Psma100718f| name: | Psma100718f | |
| ATC code: | V09IX17 | |
| route: | intravenous | |
| compartments: | 2 | |
| dosage: | 200 | mg |
| volume of distribution: | 42 | L |
| clearance: | 13 | L/h |
| other parameters in model implementation | ||
PSMA-1007 labeled with fluorine-18 is a radiopharmaceutical used in positron emission tomography (PET) imaging for the detection of prostate-specific membrane antigen (PSMA)–positive prostate cancer lesions. It is not used as a therapeutic agent but as a diagnostic tracer, approved for clinical use in numerous countries for prostate cancer imaging.
Pharmacokinetic data in adult male patients with prostate cancer undergoing PET imaging after intravenous injection.